Serum Institute of India Ltd., the world’s largest vaccine manufacturer and a key supplier of Covid-19 inoculations to developing countries, has stopped (April 22) making fresh batches of shots after its stockpile grew to 200 million doses amid a global supply glut.
“We have got 200 million doses of stock. We had to shut down production in December,” Serum’s chief executive officer Adar Poonawalla said at the India Economic Conclave organized by Times Network on Friday, saying he was worried about wastage if the shots expired. “I have even offered to give free donations to whoever wanted to take it.”
The chief executive blamed increased vaccine fatigue among the public…
“Once the perception set in that omicron is less likely to lead to severe illness, and the vaccines don’t do a great job at preventing infection….. Read More Bloomberg, Fierce Pharma